1. Cholecystokinin-2/gastrin antagonists: 5-hydroxy-5-aryl-pyrrol-2-ones as anti-inflammatory analgesics for the treatment of inflammatory bowel disease
   E. Lattmann et al, 2017, Med. Chem. Commun. CrossRef
2. Adjuvant chemotherapy with melatonin for targeting human cancers: A review
   Masoud Najafi et al, 2018, J Cell Physiol CrossRef
3. N‒substituted 5‒hydroxy‒pyrrol‒2‒ones based cholecystokinin‒2 antagonists as experimental anticancer agents for the treatment of lung cancer
   Eric Lattmann, 2018, MOJDDT CrossRef
4. Cholecystokinin Antagonists: Fluorinated 5-Hydroxy-5-Aryl-Pyrrol-2-Ones as Experimental Agents for Brain, Colon and Pancreatic Cancer
   Eric Lattmann et al, 2018, JCPCR CrossRef
5. Cholecystokinin receptor antagonist suppresses melanoma growth by inducing apoptosis of tumor cells
   Atsuko Funakoshi et al, 2022, JID Innovations CrossRef